ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Dual-Carbon Synergistic Strategy Enabling SbPO
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Antimony-based anodes have emerged as up-and-coming alloy-type anode materials for sodium-ion batteries (SIBs), owing to their high theoretical capacity and excellent electrical conductivity. However, they still suffer from severe issues such as substantial volume expansion during the sodiation-desodiation process. The novel antimony phosphate/carbon composites are designed through a multi-composited strategy in this work. The exceptional electrochemical performance of the synthesized phosphate/carbon composites arises from the synergistic combination of the unique physicochemical properties of antimony phosphate, the structural flexibility and high electrical conductivity of graphene oxide (GO), and the advantageous features of melamine-resin-derived nitrogen-doped porous carbon. For instance, the SbPO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.